Winningham Rick E
CIK 0001302443
CHIEF EXECUTIVE OFFICERDirector
Filings
32
Latest May 27, 2026
Issuers covered
2
Showing
32 of 32
Page 1
Track record
2 of 3 open-market trades scored (67% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 100% | +6.1% | +6.1% | +8.0% | +4.2% |
| 90 days | 2 | 100% | +9.9% | +9.9% | +12.9% | +6.9% |
| 180 days | 2 | 50% | -8.0% | -8.0% | +11.3% | -27.2% |
| 365 days | 1 | 100% | +20.2% | +20.2% | +20.2% | +20.2% |
Issuers
Companies where Winningham Rick E has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TBPH | Theravance Biopharma, Inc. | 27 | May 22, 2026 |
| JAZZ | Jazz Pharmaceuticals PLC | 5 | May 27, 2026 |
All filings
32 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|